JP Morgan Chase
FURX

JP Morgan Chase’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

JP Morgan Chase’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-232,991
Closed -$24.7M – 4396
2014
Q2 		$24.7M Buy
232,991
+193,005
+483% +$18.9M 0.01% 1205
2014
Q1 		$3.48M Sell
39,986
-12,417
-24% -$959K ﹤0.01% 2285
2013
Q4 		$2.2M Sell
52,403
-50,782
-49% -$2.09M ﹤0.01% 2689
2013
Q3 		$4.54M Buy
103,185
+1,394
+1% +$57.7K ﹤0.01% 2249
2013
Q2 		$3.47M Buy
+101,791
New +$3.57M ﹤0.01% 2389

JP Morgan Chase's FURX Position: Q3 2014 in Review

JP Morgan Chase sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 232,991 shares — an estimated $24.7M sold.

JP Morgan Chase first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $24.7M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • JP Morgan Chase reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • JP Morgan Chase sold 232,991 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $24.7M.
  • JP Morgan Chase first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • JP Morgan Chase's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $24.7M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on JP Morgan Chase's 13F filing for Q3 2014, filed 14 Nov 2014.